PPTA Twitter

PlasmaProteins
PlasmaProteins Next month, @PlasmaProteins will hold its annual Fly-In on Capitol Hill! PPTA, its membership, and stakeholders will advocate for patient protections & the importance of prohibitions on lifetime and annual caps for people who need #plasmaprotein therapies. bit.ly/2FRKqnR
About 7 hours ago.
PlasmaProteins
PlasmaProteins Today marks #WorldHemophiliaDay . Hemophilia A affects 1 in 10,000 people; hemophilia B is less common & affects just 1 in 25,000. Today we raise awareness of those living with these rare conditions and the #plasmaprotein therapies used to help them live a healthier life. #WHD2019 pic.twitter.com/IJ8MZiqYNA
1 day ago.

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100